# FF/UMEC/VI Inhaler: Qualitative Analysis and Subject Preference Survey

> **NCT03046069** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 634 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **OTHER:** Telephone interviews
- **OTHER:** In-person focus groups
- **OTHER:** DCE surveys- cognitive interviews
- **OTHER:** Modified DCE
- **OTHER:** Online DCE survey

## Key facts

- **NCT ID:** NCT03046069
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-20
- **Primary completion:** 2018-02-23
- **Final completion:** 2018-02-23
- **Target enrollment:** 634 (ACTUAL)
- **Last updated:** 2020-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03046069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03046069, "FF/UMEC/VI Inhaler: Qualitative Analysis and Subject Preference Survey". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03046069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*